About Avon Organics
Avon Organics is a publicly listed company based in Hyderabad (India) founded in 1993. Limited information available. The company has 1 employees. Its Indian entity Kobo Biotech Limited reported revenue of ₹1.5 Lakh.
- Headquarters Hyderabad, India
- Employees 1
- Stage Public
- Website avonorganicsltd.com
- Legal Name Kobo Biotech Limited
- Date of Incorporation 03 Aug, 1993
- Jurisdiction Hyderabad, Telangana, India
- Market Cap₹9.22 Cr
KOBO · BSE
- Share Price₹3.80
-1.81% today
- Revenue₹103 Cr
FY 2014-15 · 0.0% YoY
- EBITDA−₹0.91 Cr
Margin -0.9%
- Net Profit−₹34.80 Cr
FY 2014-15 · 0.0% YoY
- Debt / Equity3.38
Interest cover -227.7x
- Employee Count1
Associated legal entities of Avon Organics
Avon Organics operates through Kobo Biotech Limited, a listed company (under cirp). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kobo Biotech Limited Listed CIN L24110TG1993PLC016112 | Under Cirp | 03 Aug 1993 | Hyderabad, Telangana | ₹0.0 Cr | 1 | 5 | View details |
Board of directors of Kobo Biotech Limited (Avon Organics)
Kobo Biotech Limited is the primary company behind Avon Organics. The board of Kobo Biotech Limited currently have 4 directors; the longest-serving is Ajit Annu Kamath, appointed in 2009. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajit Annu Kamath DIN 00032799 | Director | 31 Jan 2009 | 17 yrs 8 mo | Kobo Biotech Limited |
| Rajendrakumar Padmanabhan Kaimal DIN 00032839 | Director | 30 May 2013 | 13 yrs 5 mo | Kobo Biotech Limited |
| Sunil Mansukhlal Pitroda DIN 07028212 | Director | 31 Mar 2018 | 8 yrs 6 mo | Kobo Biotech Limited |
| Urja Vijaykumar Shah DIN 06672899 | Director | 27 Dec 2018 | 7 yrs 10 mo | Kobo Biotech Limited |
IPO & Listings of Avon Organics
Avon Organics is a publicly listed company on the BSE with ticker symbol KOBO in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onBSE: KOBO
- Listed entityKobo Biotech Limited
- Exchange sectorPharmaceuticals
Financials of Avon Organics
Exchange-reported figures of Kobo Biotech Limited, the listed company behind Avon Organics (BSE: KOBO).
Financial Highlights
FY 2014-15 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|
| Income statement | |||
| Revenue | 103 | 103 | 404 |
| Revenue growth | 0.0% | -74.4% | - |
| EBITDA | (0.91) | (0.91) | 42.87 |
| EBITDA margin | -0.9% | -0.9% | +10.6% |
| Profit before tax | (34.26) | (34.26) | 14.86 |
| Net profit | (34.80) | (34.80) | 13.98 |
| Net profit margin | -33.7% | -33.7% | +3.5% |
| EPS (₹) | (15.47) | 0.00 | 6.22 |
| Balance sheet | |||
| Total assets | 264 | 264 | 302 |
| Net worth | 53.08 | 53.08 | 87.89 |
| Total debt | 179 | 179 | 182 |
| Cash & bank | 5.64 | 5.64 | 16.48 |
| Net working capital | 161 | 161 | 193 |
| Cash flow | |||
| Cash from operations | 6.72 | 6.72 | 36.72 |
| Cash from investing | (4.71) | (4.71) | (6.99) |
| Cash from financing | (12.85) | (12.85) | (38.39) |
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | (1.23) | (0.88) | (1.50) | (10.50) | (2.78) | (0.69) | (3.90) |
| Profit before tax | (5.22) | (4.93) | (5.55) | (15.22) | (19.22) | (21.01) | (24.46) |
| Net profit | (5.22) | (4.93) | (5.55) | (15.22) | (19.22) | (21.01) | (22.28) |
| EPS (₹) | (2.20) | (2.07) | (2.33) | (6.39) | (8.07) | (8.82) | (10.27) |
| Balance sheet | |||||||
| Total assets | 3.33 | 8.56 | 13.64 | 20.06 | 155 | 165 | 172 |
| Net worth | (138) | (133) | (128) | (122) | (107) | (87.97) | (66.96) |
| Total debt | 140 | 140 | 140 | 141 | 261 | 251 | 236 |
| Cash & bank | 4.36 | 0.18 | 0.13 | 0.13 | 1.56 | 0.13 | 0.13 |
| Net working capital | (23.13) | (21.97) | (20.96) | (18.60) | 87.07 | 90.91 | 91.64 |
| Cash flow | |||||||
| Cash from operations | 4.18 | 0.20 | 0.87 | 93.76 | 2.51 | 14.48 | 20.95 |
| Cash from investing | 0.00 | 0.00 | 0.00 | 25.09 | 0.00 | 0.00 | 0.00 |
| Cash from financing | 0.00 | (0.15) | (0.87) | (120) | (1.08) | (14.47) | (20.95) |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.34 | 0.25 | 0.20 | 0.20 | 0.23 | 0.79 | 0.17 | 0.21 |
| EBITDA | (0.34) | (0.25) | (0.20) | (0.20) | (0.23) | (0.79) | (0.17) | (0.21) |
| Depreciation | 1.01 | 1.01 | 1.03 | 1.02 | 1.01 | 1.00 | 1.03 | 0.89 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.33) | (1.26) | (1.23) | (1.22) | (1.22) | (1.79) | (1.20) | (1.10) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|
| Revenue | 103 | 103 | 404 |
| Revenue growth | 0.0% | -74.4% | - |
| Other income | 0.25 | 0.25 | 0.37 |
| Total expenses | 104 | 104 | 361 |
| Employee cost | 9.03 | 9.03 | 12.25 |
| EBITDA | (0.91) | (0.91) | 42.87 |
| EBITDA margin | -0.9% | -0.9% | +10.6% |
| Depreciation | 9.62 | 9.62 | 9.97 |
| Interest | 23.98 | 23.98 | 18.41 |
| Profit before tax | (34.26) | (34.26) | 14.86 |
| Tax | 0.54 | 0.54 | 1.21 |
| Net profit | (34.80) | (34.80) | 13.98 |
| Net profit margin | -33.7% | -33.7% | +3.5% |
| EPS (₹) | (15.47) | 0.00 | 6.22 |
| Particulars | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 22.50 | 22.50 | 22.50 |
| Reserves & surplus | 30.58 | 30.58 | 65.39 |
| Shareholders' funds (net worth) | 53.08 | 53.08 | 87.89 |
| Minority interest | 0.00 | 0.00 | 0.00 |
| Secured loans | 163 | 163 | 143 |
| Unsecured loans | 16.05 | 16.05 | 38.68 |
| Total debt | 179 | 179 | 182 |
| Total liabilities | 264 | 264 | 302 |
| Assets | |||
| Gross block | 192 | 192 | 187 |
| Net block | 104 | 104 | 108 |
| Capital work in progress | 2.25 | 2.25 | 2.92 |
| Investments | 0.00 | 0.00 | 0.00 |
| Inventories | 76.01 | 76.01 | 59.31 |
| Sundry debtors | 190 | 190 | 205 |
| Cash & bank balances | 5.64 | 5.64 | 16.48 |
| Loans & advances | 18.53 | 18.53 | 20.47 |
| Total current assets | 290 | 290 | 301 |
| Total current liabilities | 129 | 129 | 108 |
| Net working capital | 161 | 161 | 193 |
| Total assets | 264 | 264 | 302 |
| Particulars | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|
| Opening cash | 16.48 | 16.48 | 25.14 |
| Net cash from operating activities | 6.72 | 6.72 | 36.72 |
| Net cash from investing activities | (4.71) | (4.71) | (6.99) |
| Net cash from financing activities | (12.85) | (12.85) | (38.39) |
| Net change in cash | (10.84) | (10.84) | (8.66) |
| Closing cash | 5.64 | 5.64 | 16.48 |
| Particulars | FY 2014-15 | FY 2013-14 | FY 2012-13 |
|---|---|---|---|
| Growth | |||
| Sales growth | 0.0% | -74.4% | - |
| EBITDA growth | 0.0% | -102.1% | - |
| PBT growth | 0.0% | - | +9997.0% |
| Net income growth | 0.0% | -348.9% | - |
| Profitability & leverage | |||
| Net income margin | -33.7% | -33.7% | +3.4% |
| Return on capital employed | 0.0% | 0.0% | +12.6% |
| Return on net worth | 0.0% | 0.0% | +16.7% |
| Debt / equity | 3.38 | 2.56 | 1.83 |
| Long-term debt / equity | 0.70 | 0.55 | 0.52 |
| Interest cover | -227.73 | -227.73 | 55.96 |
| Efficiency & per share | |||
| Fixed asset turnover | 0.54 | 0.55 | 2.32 |
| Inventory turnover | 1.37 | 1.54 | 7.98 |
| Debtors turnover | 0.55 | 0.53 | 2.35 |
| EPS (₹) | (15.47) | 0.00 | 6.22 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 23.59 | 23.59 | 39.06 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.34 | 0.25 | 0.20 | 0.20 | 0.23 | 0.79 | 0.17 | 0.21 |
| EBITDA | (0.34) | (0.25) | (0.20) | (0.20) | (0.23) | (0.79) | (0.17) | (0.21) |
| Depreciation | 1.01 | 1.01 | 1.03 | 1.02 | 1.01 | 1.00 | 1.03 | 0.89 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (1.33) | (1.26) | (1.23) | (1.22) | (1.22) | (1.79) | (1.20) | (1.10) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.08 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
| Total expenses | 1.23 | 0.88 | 1.50 | 10.50 | 2.78 | 0.69 | 3.90 |
| Employee cost | 0.19 | 0.25 | 0.23 | 0.72 | 1.39 | 1.80 | 2.08 |
| EBITDA | (1.23) | (0.88) | (1.50) | (10.50) | (2.78) | (0.69) | (3.90) |
| Depreciation | 4.07 | 4.07 | 4.07 | 4.61 | 5.64 | 5.88 | 6.15 |
| Interest | 0.00 | 0.00 | 0.00 | 0.13 | 10.84 | 14.47 | 14.44 |
| Profit before tax | (5.22) | (4.93) | (5.55) | (15.22) | (19.22) | (21.01) | (24.46) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | (5.22) | (4.93) | (5.55) | (15.22) | (19.22) | (21.01) | (22.28) |
| EPS (₹) | (2.20) | (2.07) | (2.33) | (6.39) | (8.07) | (8.82) | (10.27) |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
| Reserves & surplus | (162) | (157) | (152) | (146) | (131) | (112) | (90.79) |
| Shareholders' funds (net worth) | (138) | (133) | (128) | (122) | (107) | (87.97) | (66.96) |
| Secured loans | 108 | 108 | 108 | 109 | 229 | 219 | 205 |
| Unsecured loans | 31.71 | 31.71 | 31.71 | 31.71 | 31.71 | 31.71 | 31.71 |
| Total debt | 140 | 140 | 140 | 141 | 261 | 251 | 236 |
| Total liabilities | 3.33 | 8.56 | 13.64 | 20.06 | 155 | 165 | 172 |
| Assets | |||||||
| Gross block | 104 | 104 | 104 | 104 | 192 | 192 | 192 |
| Net block | 29.45 | 33.52 | 37.59 | 41.66 | 56.91 | 62.54 | 68.42 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 2.25 | 2.25 | 2.25 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 12.19 | 12.19 | 12.19 |
| Inventories | 18.04 | 18.04 | 18.04 | 18.04 | 53.28 | 53.28 | 53.28 |
| Sundry debtors | 12.01 | 11.97 | 11.95 | 11.80 | 92.47 | 93.29 | 90.61 |
| Cash & bank balances | 4.36 | 0.18 | 0.13 | 0.13 | 1.56 | 0.13 | 0.13 |
| Loans & advances | 7.73 | 7.69 | 7.62 | 7.56 | 11.92 | 12.65 | 12.56 |
| Total current assets | 42.14 | 37.88 | 37.74 | 37.53 | 159 | 159 | 157 |
| Total current liabilities | 65.27 | 59.85 | 58.70 | 56.13 | 72.16 | 68.44 | 64.94 |
| Net working capital | (23.13) | (21.97) | (20.96) | (18.60) | 87.07 | 90.91 | 91.64 |
| Total assets | 3.33 | 8.56 | 13.64 | 20.06 | 155 | 165 | 172 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.18 | 0.13 | 0.13 | 1.56 | 0.13 | 0.13 | 0.13 |
| Net cash from operating activities | 4.18 | 0.20 | 0.87 | 93.76 | 2.51 | 14.48 | 20.95 |
| Net cash from investing activities | 0.00 | 0.00 | 0.00 | 25.09 | 0.00 | 0.00 | 0.00 |
| Net cash from financing activities | 0.00 | (0.15) | (0.87) | (120) | (1.08) | (14.47) | (20.95) |
| Net change in cash | 4.18 | 0.05 | 0.00 | (1.43) | 1.43 | 0.00 | 0.00 |
| Closing cash | 4.36 | 0.18 | 0.13 | 0.13 | 1.56 | 0.13 | 0.13 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| EBITDA growth | -39.8% | +41.3% | +85.7% | -277.7% | -302.9% | +82.3% | - |
| PBT growth | -5.9% | +11.2% | +63.5% | +20.8% | +8.5% | +14.1% | -2.3% |
| Net income growth | -5.9% | +11.2% | +63.5% | +20.8% | +8.5% | +5.7% | - |
| Revenue CAGR (3Y) | - | - | - | - | - | - | -100.0% |
| EBITDA CAGR (3Y) | -51.1% | -31.9% | +29.5% | +39.1% | -2.7% | -44.5% | - |
| Profitability & leverage | |||||||
| Return on capital employed | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on net worth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | -0.86 | -128.74 | -220.24 | -143.68 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (₹) | (2.20) | (2.07) | (2.33) | (6.39) | (8.07) | (8.82) | (10.27) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | (57.98) | (55.79) | (53.72) | (51.39) | (45.00) | (36.92) | (28.11) |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avon Organics
Complete news archive for Avon Organics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avon Organics
Avon Organics was founded in 1993.
Avon Organics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Avon Organics has 1 employees.
The primary company behind Avon Organics, Kobo Biotech Limited, reported revenue of ₹1.5 Lakh for FY 2023, down 8% year on year.
Limited information available.
Yes, Avon Organics is publicly traded on BSE under the ticker symbol KOBO.
Avon Organics operates through Kobo Biotech Limited.
The legal entities of Avon Organics currently have 5 directors, including Sunil Mansukhlal Pitroda, Ajit Annu Kamath, Urja Vijaykumar Shah and others.

